HarmoniaMentis SverigeHarmoniaMentis Sverige
  1. Home
  2. Educational Offering
  3. From Now On, Milan 2023

  4. You are here: Paul Boon: The importance of brain health and the burden of neurological disorders

Paul Boon: The importance of brain health and the burden of neurological disorders

In this session Paul Boon discusses the unmet needs in brain health, the high burden of neuro­logical disorders and epilepsy, and the strategies being used to reduce the burden and improve brain health.

The burden of neurological disorders is the highest among 21 disease categories worldwide,1 and despite recent progress, epilepsy remains a major cause of disability and mortality, with a prevalence of 621.5 per 100 000.2 Significant gains in reducing the burden of epilepsy are expected from improved access to treatment in low-income countries and new, effective drugs.2

Prof. Paul Boon is the chairman and senior full professor of neurology at Ghent University Hospital, director of 4Brain at Ghent University and the president of the European Academy of Neurology (EAN).

This slide deck was presented by Prof. Paul Boon at the "From Now On" meeting 28.11.2023. The meeting was arranged and funded by Angelini Pharma S.p.a. The opinions expressed in the slides are solely those of the presenter and not necessarily those of Angelini Pharma. Angelini Pharma does not guarantee the accuracy or reliability of the information herein.

 

Lecture slides

 

 

References

  1. Deuschl G, Beghi E, Fazekas F et al. The burden of neurological diseases in Europe: an analysis for the Global Burden of disease study 2017. Lancet Public Health. 2020 Oct;5(10):e551-e567
  2. Beghi E, Giussani G, Nichols E et al. (GBD Epilepsy Collaborators). Global, regional, and national burden of epilepsy, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2019 Apr;18(4):357-375

SW23954P June 2024

;